Small molecules that can represent a new class of anticancer drugs with a novel target for the treatment of lung cancer have been identified by an interdisciplinary team of researchers. “These compounds hold potential as an entirely new class of anticancer drugs with a unique therapeutic target for the treatment of cancers,” one expert noted.